According to Seattles website dated May 5,2017 they pulled their 2B offer after 2 ceo's got axed and proxy fight with venbio...but looks like they also have a triple breast cancer drug already...just saying
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links